TRIBE2: Latest data for patients with mCRC

Cancer care in Latin America

Getting high level care to low and middle income countries

Guidelines for prepectoral implant-based breast reconstruction

Latest advances in pancreatic cancer treatment and impact on practice

Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL

Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM

ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone

HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide

Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer

DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer